Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …